OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dihydroartemisinin elicits immunogenic death through ferroptosis-triggered ER stress and DNA damage for lung cancer immunotherapy
Ning Han, Ziyi Yang, Zhong-Xiong Xie, et al.
Phytomedicine (2023) Vol. 112, pp. 154682-154682
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

The mechanism of ferroptosis and its related diseases
Shijian Feng, Dan Tang, Yichang Wang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 62

The crosstalk between ferroptosis and anti‐tumor immunity in the tumor microenvironment: molecular mechanisms and therapeutic controversy
Yichen Zheng, Lingqi Sun, Jiamin Guo, et al.
Cancer Communications (2023) Vol. 43, Iss. 10, pp. 1071-1096
Open Access | Times Cited: 38

A Dihydroartemisinin‐Loaded Nanoreactor Motivates Anti‐Cancer Immunotherapy by Synergy‐Induced Ferroptosis to Activate Cgas/STING for Reprogramming of Macrophage
Liu‐Gen Li, Xiaoxin Yang, Hua‐Zhen Xu, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 28
Closed Access | Times Cited: 27

Natural product-derived ferroptosis mediators
Yili Chen, Lin-An Xiong, Lie‐Feng Ma, et al.
Phytochemistry (2024) Vol. 219, pp. 114002-114002
Closed Access | Times Cited: 12

Targeting ferroptosis unveils a new era for traditional Chinese medicine: a scientific metrology study
Siyang Cao, Yihao Wei, Yaohang Yue, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10

A Cancer Nanovaccine Based on an FeAl-Layered Double Hydroxide Framework for Reactive Oxygen Species-Augmented Metalloimmunotherapy
Mengyu Chang, Man Wang, Bin Liu, et al.
ACS Nano (2024) Vol. 18, Iss. 11, pp. 8143-8156
Closed Access | Times Cited: 10

Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer
Xin Jin, Wenke Jin, L. Tong, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2815-2853
Open Access | Times Cited: 8

Traditional Chinese medicine in lung cancer treatment
Zhichao Xi, Rongchen Dai, Yufei Ze, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1

Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy
Sihui Yu, Hongyang Xiao, Li Ma, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 5, pp. 188946-188946
Closed Access | Times Cited: 20

Drug Repurposing‐Based Brain‐Targeting Self‐Assembly Nanoplatform Using Enhanced Ferroptosis against Glioblastoma
Jiantang Liang, Lei Li, Hailong Tian, et al.
Small (2023) Vol. 19, Iss. 46
Open Access | Times Cited: 18

Recent advances in natural compounds inducing non-apoptotic cell death for anticancer drug resistance
Jiawen Chen, Sibao Chen, Guoqing Chen
Cancer Drug Resistance (2023) Vol. 6, Iss. 4, pp. 709-27
Open Access | Times Cited: 17

Emerging trends of phytochemicals as ferroptosis modulators in cancer therapy
Fahad Khan, Pratibha Pandey, Meenakshi Verma, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116363-116363
Open Access | Times Cited: 6

Tumor-associated macrophages affect the treatment of lung cancer
Zhuchen Yu, Juntao Zou, Fei Xu
Heliyon (2024) Vol. 10, Iss. 7, pp. e29332-e29332
Open Access | Times Cited: 6

Dihydroartemisinin‐driven TOM70 inhibition leads to mitochondrial destabilization to induce pyroptosis against lung cancer
Liu‐Gen Li, Jun Hu, Ning Han, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 8, pp. 3856-3876
Closed Access | Times Cited: 6

Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products
Lele Zhang, Du-Juan Zhang, Jia-Xin Shi, et al.
Phytomedicine (2024) Vol. 132, pp. 155828-155828
Closed Access | Times Cited: 6

Spotlight on iron and ferroptosis: research progress in diabetic retinopathy
Junlin Ouyang, Ling Zhou, Qing Wang
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 13

Inducing ferroptosis by traditional medicines: a novel approach to reverse chemoresistance in lung cancer
Yumin Wang, Jing Hu, Joshua S. Fleishman, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4

Targeting ferroptosis: a promising approach for treating lung carcinoma
Ziyang Wu, Tao Zhang, Wei Zhong, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access

Bibliometric analysis of ferroptosis: a comprehensive evaluation of its contribution to lung cancer
Feifei Yao, Feng Guo, Chengyi Sun, et al.
Frontiers in Genetics (2025) Vol. 15
Open Access

Synergistic Strategies for Lung Cancer Immunotherapy: Combining Phytochemicals and Immune‐Checkpoint Inhibitors
Quan Gao, Hao Wu, Zhengjun Li, et al.
Phytotherapy Research (2025)
Closed Access

Targeting HSP70 chaperones by rhein sensitizes liver cancer to artemisinin derivatives
Jiao Wang, Jin Zhang, Zeyu Guo, et al.
Phytomedicine (2023) Vol. 122, pp. 155156-155156
Closed Access | Times Cited: 10

The Mutual Regulatory Role of Ferroptosis and Immunotherapy in Anti-tumor Therapy
Zhiguo Mao, Yilong Hu, Yinan Zhao, et al.
APOPTOSIS (2024)
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top